This could lead to a potential treatment to replace damaged eye cells in conditions such as retinitis pigmentosa or macular degeneration.
Thirty million to 40 million people around the world suffer from retinitis pigmentosa or macular degeneration, two diseases in which the retina--a thin sheet of cells in the back .
Thirty million to 40 million people around the world suffer from retinitis pigmentosa or macular degeneration, two diseases in which the retina a thin sheet of cells in the .
Retina Implant AG's Alpha IMS Wins CE Mark REUTLINGEN, Germany, July 3, 2013 /PRNewswire/ -- Retina Implant AG , the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that its wireless ...
July 3, 2013 - PR Newswire via Yahoo! Finance
World's first approved bionic eye to launch in U.S. The Argus II, which treats patients with the rare genetic condition known as retinitis pigmentosa, was approved by the FDA in February after more than 20 years in the making.
July 2, 2013 - CNET